Avalo Therapeutics, Inc. · NASDAQ:AVTX

Varki Paul received 24,300 Avalo Therapeutics, Inc. shares as an award (Form 4)

Traded May 21, 2026 · Filed May 26, 2026

On May 21, 2026, Varki Paul (Chief Legal Officer) received 24,300 Avalo Therapeutics, Inc. shares as an award, leaving 27,934 shares. Filed May 26, 2026 (Form 4).

Awarded
24,300 shares
Holding after
27,934 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockAward24,30027,934Direct

Source

View original at SEC

Related